Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
Syed Ehsan Shah, Hemostasis Key Account Manager at Werfen, shared on LinkedIn:
”This week in Basel, Switzerland Werfen EEMEA together with AFMS team hosted a one-day session on automation in Hemostasis laboratories for our customers from Saudi Arabia.
It was a great opportunity to share knowledge about Werfen Hemostasis Solutions for big specialized hemostasis centers and explore how Werfen automation-HemoCell can truly transform daily hemostasis lab operations.
In the afternoon, participants had the chance to see the HemoCell automation in action in Basel University.
The laboratory supervisor shared valuable insights, highlighting key advantages such as:
- Less than 30 minutes turnaround time
- Full sample traceability
- Complex reflex rules for factor assays
- Reduced staff workload
A big thanks to all the participants and our team members who joined and contributed to the discussions — it’s always inspiring to see how Werfen innovation in Hemostasis continues to enhance lab efficiency and patient care.
Special thanks to Elias Bouchi, Gianpaolo Pozzato and Ahmed Abbas for your support and dedication.”

Stay updated with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD
